Viewing Study NCT04166734

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2026-03-04 @ 8:38 PM
Study NCT ID: NCT04166734
Status: TERMINATED
Last Update Posted: 2023-08-07
First Post: 2019-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma
Sponsor: Royal Marsden NHS Foundation Trust
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignant Pleural Mesothelioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced malignant pleural mesothelioma View
None mesothelioma View
None pembrolizumab View
None radiotherapy View
None SBRT View
None External Beam Stereotactic Body Radiotherapy View